封面
市場調查報告書
商品編碼
2076036

熱療癌症治療市場:按治療類型、應用、最終用戶和地區分類

Hyperthermia Cancer Treatment Market, By Treatment Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,到 2026 年,熱療癌症治療市場規模將達到 2.238 億美元,預計到 2033 年將達到 3.432 億美元。預計從 2026 年到 2033 年,該市場將以 6.3% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2.238億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.30% 2033年市場規模預測: 3.432億美元

熱療是一種利用熱能治療癌細胞的新型療法。它透過外部熱源或直接用熱能照射腫瘤部位來提高癌細胞的溫度。當熱療與其他癌症療法(例如化療和放射線治療)合併使用時,可增強其療效。

熱療旨在透過高溫殺死癌細胞,增強放射線治療的療效,並促進化療藥物的吸收。這是一種非侵入性治療方法,因其與傳統療法相比具有改善患者預後和最大限度減少副作用的潛力,在腫瘤學領域備受關注。

市場動態:

全球熱療癌症治療市場預計在預測期內將顯著成長。推動這一成長的市場動態包括全球癌症發生率上升、創新癌症療法的普及以及技術進步等。

全球癌症患者數量的不斷成長是推動熱療癌症治療市場發展的主要因素之一。根據國際癌症研究機構(IARC)2021年5月發布的數據,2020年全球新增癌症病例估計達1,930萬例。癌症發病率的上升預計將推動對包括熱療在內的有效治療方法的需求。

此外,熱療設備的科技進步可望推動市場成長。局部和全身熱療等先進加熱技術的發展,提高了治療效果,並擴大了熱療的應用範圍。此外,熱療設備與影像診斷設備的整合,實現了即時溫度監測和對癌細胞的精準靶向照射,進一步提升了治療效果。

儘管市場潛力巨大,但某些因素可能會限制其成長。醫護人員和病患對高溫療法的認知度較低、治療費用高昂、保險報銷的挑戰等,都是可能阻礙市場擴張的因素。然而,透過提高公眾認知度、制定有利的保險報銷政策以及持續進行研發活動,這些挑戰有望得到克服。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 全球熱療癌症治療市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球熱療癌症治療市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 全球癌症發生率正在上升。
    • 抑制因子
      • 熱療系統高成本
    • 機會
      • 奈米顆粒在熱療上的應用越來越廣泛。
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 熱療癌症治療市場:依治療類型分類,2021-2033年

  • 局部熱療
  • 局部熱療
  • 全身熱療

第5章 熱療癌症治療市場:依應用領域分類,2021-2033年

  • 攝護腺癌
  • 乳癌
  • 子宮頸癌
  • 皮膚癌
  • 其他癌症

第6章 熱療癌症治療市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診所
  • 專業醫療中心
  • 其他(學術和研究機構)

第7章 熱療癌症治療市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • MagForce AG
  • Andromedic Srl
  • Celsius42 GmbH
  • Oncotherm Kft
  • Pyrexar Medical
  • YAMAMOTO VINITA CO.,LTD
  • Nanoprobes
  • Alba Hyperthermia System
  • Novavida
  • Sensius

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6415

Hyperthermia Cancer Treatment Market is estimated to be valued at USD 223.8 Mn in 2026 and is expected to reach USD 343.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 223.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.30% 2033 Value Projection: USD 343.2 Mn

Hyperthermia cancer treatment is a novel therapeutic approach that utilizes heat to treat cancer cells. It involves raising the temperature of cancerous cells, either from external sources or by directing heat specifically to the tumor site. Hyperthermia can be used in conjunction with other cancer treatments like chemotherapy and radiation therapy to improve their efficacy.

By subjecting malignant cells to higher temperatures, hyperthermia treatment aims to kill cancer cells, enhance the effectiveness of radiation therapy, and increase the uptake of chemotherapeutic agents. It is a non-invasive method that is gaining momentum in the field of oncology due to its potential to improve patient outcomes and minimize side effects compared to traditional treatments.

Market Dynamics:

The global hyperthermia cancer treatment market is expected to experience significant growth during the forecast period. The market dynamics driving this growth include various factors such as the rising prevalence of cancer worldwide, increasing adoption of innovative cancer treatment methods, and advancements in technology.

Rising cases of cancer globally is one of the key drivers of the Hyperthermia cancer treatment market. According to the data published by the International Agency for Research on Cancer in May 2021, an estimated 19.3 million new cancer cases occurred in 2020. This growing incidence of cancer is expected to fuel demand for effective treatment options, including hyperthermia therapy.

Moreover, technological advancements in hyperthermia treatment devices are expected to propel market growth. The development of advanced heating techniques, such as regional and whole-body hyperthermia, has improved treatment outcomes and expanded the applicability of hyperthermia therapy. Additionally, the integration of hyperthermia devices with imaging modalities allows for real-time temperature monitoring and precise targeting of tumor cells, further enhancing treatment efficacy.

While the market holds immense potential, certain factors may restrain its growth. Limited awareness about hyperthermia treatment among healthcare professionals and patients, high treatment costs, and reimbursement challenges are some of the obstacles that may hinder market expansion. However, efforts to increase awareness, favorable reimbursement policies, and ongoing research and development activities are expected to overcome these challenges.

Key Features of the Study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include MagForce AG, Andromedic S.r.l., Celsius42 GmbH, Oncotherm Kft, Pyrexar Medical, YAMAMOTO VINITA CO.,LTD, Nanoprobes, Alba Hyperthermia System, Novavida, and Sensius.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgradation, market expansion, and marketing tactics.
  • The global hyperthermia cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hyperthermia cancer treatment market

Hyperthermia Cancer Treatment Market Detailed Segmentation:

  • By Treatment Type (Revenue, USD Mn, 2021 - 2033)
  • Local Hyperthermia
  • Regional Hyperthermia
  • Whole Body Hyperthermia
  • By Application (Revenue, USD Mn, 2021 - 2033)
  • Prostate Cancer
  • Breast Cancer
  • Cervical Cancer
  • Skin Cancer
  • Other Cancers
  • By End User (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Clinic
  • Specialty Centres
  • Others (Academic and Research Institute)
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top companies in Hyperthermia Cancer Treatment Market:
  • MagForce AG
  • Andromedic S.r.l.
  • Celsius42 GmbH
  • Oncotherm Kft
  • Pyrexar Medical
  • YAMAMOTO VINITA CO.,LTD
  • Nanoprobes
  • Alba Hyperthermia System
  • Novavida
  • Sensius

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hyperthermia Cancer Treatment Market, By Treatment Type
    • Global Hyperthermia Cancer Treatment Market, By Application
    • Global Hyperthermia Cancer Treatment Market, By End User
    • Global Hyperthermia Cancer Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Increasing prevalence of cancer worldwide
    • Restraints
      • High costs of hyperthermia systems
    • Opportunities
      • Growing popularity of nanoparticle-mediated hyperthermia
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hyperthermia Cancer Treatment Market , By Treatment Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Local Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Regional Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Whole Body Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Hyperthermia Cancer Treatment Market , By Application, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Hyperthermia Cancer Treatment Market , By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Clinic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Others (Academic and Research Institute)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Hyperthermia Cancer Treatment Market , By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2022-2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • MagForce AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Andromedic S.r.l.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsius42 GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Oncotherm Kft
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pyrexar Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • YAMAMOTO VINITA CO.,LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nanoprobes
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alba Hyperthermia System
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novavida
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sensius
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us